AI assistant
AtriCure, Inc. — Director's Dealing 2017
Mar 3, 2017
31802_dirs_2017-03-03_17c02fa5-6f03-4de7-9381-4f86009c1535.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-03-01
Reporting Person: Seith Douglas J (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-01 | Common Stock | A | 60000 | $0.00 | Acquired | 249045 | Direct |
| 2017-03-01 | Common Stock | F | 9566 | $18.95 | Disposed | 239479 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3500 | Indirect |
Footnotes
F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant.
F2: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards.
F3: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.